Development of an in vitro Assay System for Screening of gp41 Inhibitory Compounds

Molecules and Cells

Volumn 8, Issue 6, 1998, Pages 717-723

  Ryu, Jae Ryeon ^a   Lee, Jung ^a   Choo, Soeun ^a   Yoon, Seung Hee ^a   Woo, Eun Rhan ^a   Yu, Yeon Gyu ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

gp41; HIV; In vitro Assay; Inhibitor

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN GP 41; HYBRID PROTEIN; PEPTIDE FRAGMENT; THIOREDOXIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; CELL FUSION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; MEMBRANE FUSION; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BINDING, COMPETITIVE; CELL FUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE TRANSFERASE; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; THIOREDOXIN;

EID: 0032585364     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Allan, J. S. (1991) Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science 252, 1322-1323.
2. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994) The structure of influenza hemagglutinine at the pH of membrane fusion. Nature 371, 37-43.
3. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
4. Delwart, E. L., Mosialos, G., and Gilmore, T. (1990) Retroviral envelope glycoproteins contain a "leucine zipper "-like repeat. AIDS Res. Hum. Ret. 6, 703-706.
5. Feng, D., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 72, 872-877.
6. Hart, K. T., Kirsch, R., Ellens, H., Sweet, R. W., Lambert, D. M., Petteway, S. R. Jr., Learly, J., and Bugelski, P. J. (1991) Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88, 2189-2193.
7. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
8. Judice, J. C., Tom, J. Y. K., Huang, W., Wrin, T., Vennari, J., Petropoulos, C. J., and McDowell, R. S. (1997) Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implication for the viral fusion mechanism. Proc. Natl. Acad. Sci. USA 94, 13426-13430.
9. King, D. S., Field, C. G., and Field, G. B. (1990) A cleavage method which minimizes side reactions following Fmoc solid peptide synthesis. Int. J. Peptide Protein Res. 36, 255-266.
10. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
11. Lawless, M. K., Barney, S., Guthrie, K. I., Bucy, T. B., Petteway, S. R., and Merutka, G. (1996) HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35, 13697-13708.
12. Lu, M., Blacklow, S. C., and Kim, P. S. (1995) A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Structural Biology 2, 1075-1082.
13. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., and Axel, R. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
14. Moore, J. P., McKeating, J. A., Weiss, R., and Sattentau, Q. J. (1990) Dissociation of gp120 from HIV-1 induced by soluble CD4. Science 250, 1139-1142.
15. Nussbaum, O., Broder, C. C., and Berger, E. A. (1994) Fusogenic mechanisms of the enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68, 5411-5422.
16. Poumbourios, P., Wilson, K. A., Center, R. J., Ahmar, W. L., and Kemp, B. (1997) Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence. J. Virol. 71, 2041-2049.
17. Rabenstein, M. and Shin, Y.-K. (1995) A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34, 13390-13397.
18. Shaw, G. M., Hahn, B. H., Arya, S. K., Groopman, J. E., Gallo, R. C., and Wong-Staal, F. (1984) Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226, 1165-1171.
19. Shugars, D. C., Wild, C. T., Greenwell, T. K., and Matthews, T. J. (1996) Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70, 2982-2991.
20. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorf, J. W. (1990) Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60-89.
21. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
22. Wild, C., Greenwell, T., Shugars, D., Rimsky-Clarke, L., Mathews, T. (1995) The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Ret. 11, 323-325.
23. Wild, C., Oas, T., McDanal, C., Bolognesi, D., and Matthews, T. (1992) A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537-10641.
24. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T (1994) Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
25. Woo, E.-R., Yoon, S. H., Kwak, J. H., Kim, H. J., and Park, H. (1997) Inhibition of gp120-CD4 interaction by various plant extracts. Phytomedicine 4, 53-58.